Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Immunological Reviews
|
April 21, 2006
Microarray-based understanding of normal and malignant plasma cells
John De Vos, Dirk Hose, Thierry Rème, et al.
Bone Marrow Transplantation
|
September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
M Hundemer, U Klein, D Hose, et al.
Molecular Cytogenetics
|
January 7, 2011
New cytogenetically visible copy number variant in region 8q21.2
Marina Manvelyan, Friedrich W Cremer, Jeannette Lancé, et al.
European Journal of Haematology
|
October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
Jens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Genes, Chromosomes & Cancer
|
July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics
Friedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Blood
|
February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability
Tilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Cancer Genetics and Cytogenetics
|
August 17, 2005
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH
Friedrich W Cremer, Mutlu Kartal, Dirk Hose, et al.
Leukemia
|
October 8, 2004
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy
M C Minnema, I Breitkreutz, J J A Auwerda, et al.
Cancer Medicine
|
September 27, 2021
Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study
Nathalie Rippinger, Christine Fischer, Hans-Peter Sinn, et al.
Oncogene
|
May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K Mahtouk, F W Cremer, T Rème, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Immunological Reviews
|
April 21, 2006
Microarray-based understanding of normal and malignant plasma cells
John De Vos, Dirk Hose, Thierry Rème, et al.
Bone Marrow Transplantation
|
September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
M Hundemer, U Klein, D Hose, et al.
Molecular Cytogenetics
|
January 7, 2011
New cytogenetically visible copy number variant in region 8q21.2
Marina Manvelyan, Friedrich W Cremer, Jeannette Lancé, et al.
European Journal of Haematology
|
October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
Jens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Genes, Chromosomes & Cancer
|
July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics
Friedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Blood
|
February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability
Tilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Cancer Genetics and Cytogenetics
|
August 17, 2005
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH
Friedrich W Cremer, Mutlu Kartal, Dirk Hose, et al.
Leukemia
|
October 8, 2004
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy
M C Minnema, I Breitkreutz, J J A Auwerda, et al.
Cancer Medicine
|
September 27, 2021
Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study
Nathalie Rippinger, Christine Fischer, Hans-Peter Sinn, et al.
Oncogene
|
May 30, 2006
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K Mahtouk, F W Cremer, T Rème, et al.
Page
of 8